Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Steady-State pharmacokinetics and tolerability of Indinavir-Lopinavir/R Combination therapy in Antiretroviral-experienced patients

Antoniou, T., Tseng, A.L., van Heeswijk, R.P.G., Walker, S.E., Giquere, P. and Phillips, E.J. (2005) Steady-State pharmacokinetics and tolerability of Indinavir-Lopinavir/R Combination therapy in Antiretroviral-experienced patients. Therapeutic Drug Monitoring, 27 (6). pp. 779-781.

Link to Published Version: http://journals.lww.com/drug-monitoring/pages/arti...
*Subscription may be required

Abstract

Six HIV-positive antiretroviral experienced patients initiating therapy with a regimen including lopinavir/ritonavir (400/100 mg twice per day) and indinavir (800 mg twice per day) underwent steady-state pharmacokinetic analysis. The AUC0-12h of indinavir when combined with lopinavir/ritonavir was comparable with previously published data on indinavir/ritonavir 800/100 mg twice per day in HIV-infected individuals. However, lopinavir AUC0-12h, Cmax, and C12h were lower than previously reported in the absence of indinavir. The regimen was well tolerated, although 2 patients developed grade 3 hypertriglyceridemia. No patient discontinued the regimen because of indinavir-related urologic or retinoid-type adverse effects. Further study of the regimen with larger cohorts of patients is necessary.

Item Type: Journal Article
Publisher: Lippincott Williams & Wilkins
Copyright: © 2005 Lippincott Williams & Wilkins, Inc.
URI: http://researchrepository.murdoch.edu.au/id/eprint/16035
Item Control Page Item Control Page